BlackRock
NEXI

BlackRock’s NexImmune, Inc. Common Stock NEXI Stock Holding History

BlackRock’s Portfolio NEXI Stock Details NEXI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-14
Closed -$31 – 5420
2023
Q4 		$31 Hold
14
– – ﹤0.01% 5348
2023
Q3 		$76 Hold
14
– – ﹤0.01% 5400
2023
Q2 		$101 Sell
14
-1,741
-99% -$15K ﹤0.01% 5465
2023
Q1 		$16.7K Buy
1,755
+56
+3% +$588 ﹤0.01% 5274
2022
Q4 		$10.3K Buy
1,699
+525
+45% +$6.55K ﹤0.01% 5455
2022
Q3 		$16K Sell
1,174
-584
-33% -$17.1K ﹤0.01% 5547
2022
Q2 		$72K Sell
1,758
-31,201
-95% -$1.93M ﹤0.01% 5330
2022
Q1 		$3.47M Sell
32,959
-881
-3% -$64.7K ﹤0.01% 4143
2021
Q4 		$3.9M Buy
33,840
+1,333
+4% +$320K ﹤0.01% 4105
2021
Q3 		$12.3M Buy
32,507
+19,526
+150% +$6.55M ﹤0.01% 3580
2021
Q2 		$5.3M Buy
12,981
+841
+7% +$387K ﹤0.01% 3856
2021
Q1 		$5.79M Buy
+12,140
New +$6.61M ﹤0.01% 3871

Other funds holding NEXI

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
SPC
Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return
ECG
EPIQ Capital Group San Francisco, California $383M AUM 46.87% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
Comerica Bank
Comerica Bank Dallas, Texas $25.1B AUM 24.68% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

BlackRock's NEXI Position: Q1 2024 in Review

BlackRock sold out of NexImmune, Inc. Common Stock (NEXI) in Q1 2024, closing a stake of 14 shares — an estimated $31 sold.

BlackRock first reported a position in NEXI in Q1 2021 and held it in 12 quarters. The position peaked at $12.3M in Q3 2021. 12 funds tracked by Wall St. Rank hold NEXI as of Q1 2024.

  • BlackRock reported no remaining NexImmune, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • BlackRock sold 14 NexImmune, Inc. Common Stock shares in Q1 2024, an estimated $31.
  • BlackRock first reported a position in NexImmune, Inc. Common Stock in Q1 2021 and held it in 12 quarters.
  • BlackRock's NexImmune, Inc. Common Stock position peaked at $12.3M in Q3 2021.
  • 12 funds tracked by Wall St. Rank held NexImmune, Inc. Common Stock as of Q1 2024.

Based on BlackRock's 13F filing for Q1 2024, filed 10 May 2024.